Duality Advisers LP Sells 14,841 Shares of The Chemours Company (NYSE:CC)

Duality Advisers LP cut its holdings in The Chemours Company (NYSE:CCFree Report) by 68.4% during the 4th quarter, Holdings Channel reports. The fund owned 6,866 shares of the specialty chemicals company’s stock after selling 14,841 shares during the period. Duality Advisers LP’s holdings in Chemours were worth $217,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Deutsche Bank AG increased its stake in shares of Chemours by 4,407.9% in the third quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company’s stock worth $49,352,000 after purchasing an additional 1,720,389 shares in the last quarter. Anchor Investment Management LLC purchased a new position in Chemours during the fourth quarter valued at $56,000. Assenagon Asset Management S.A. purchased a new position in Chemours during the fourth quarter valued at $4,711,000. American Century Companies Inc. grew its stake in Chemours by 0.7% during the third quarter. American Century Companies Inc. now owns 1,459,463 shares of the specialty chemicals company’s stock valued at $40,938,000 after acquiring an additional 10,075 shares in the last quarter. Finally, Sherbrooke Park Advisers LLC purchased a new position in Chemours during the third quarter valued at $1,044,000. 76.26% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CC has been the subject of several research analyst reports. Barclays cut their target price on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. UBS Group increased their price objective on shares of Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research report on Tuesday, April 2nd. Finally, BMO Capital Markets upgraded shares of Chemours from an “underperform” rating to an “outperform” rating and increased their price objective for the company from $19.00 to $34.00 in a research report on Tuesday, April 9th. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $30.89.

View Our Latest Stock Report on CC

Chemours Price Performance

Chemours stock opened at $27.32 on Friday. The Chemours Company has a 12-month low of $15.10 and a 12-month high of $39.05. The firm has a 50-day moving average price of $26.72 and a 200-day moving average price of $27.79. The firm has a market capitalization of $4.07 billion, a PE ratio of -17.63 and a beta of 2.00. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40.

Chemours (NYSE:CCGet Free Report) last announced its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The company had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. As a group, equities research analysts forecast that The Chemours Company will post 2.23 EPS for the current year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were issued a dividend of $0.25 per share. The ex-dividend date was Friday, February 23rd. This represents a $1.00 dividend on an annualized basis and a yield of 3.66%. Chemours’s payout ratio is -64.52%.

Chemours Company Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Stories

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.